Reduced triphosphopyridine nucleotide oxidase-catalyzed alterations of membrane phospholipids. VI. Structural changes in mitochondria associated with inactivation of electron transport activity.
D000818:Animals; D004579:Electron Transport; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007501:Iron / Q000494:pharmacology; D007656:Ketoglutaric Acids / Q000378:metabolism; D007700:Kinetics; D050356:Lipid Metabolism; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008566:Membranes / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008933:Mitochondrial Swelling; D009249:NADP / Q000378:metabolism* / Q000494:pharmacology; D010085:Oxidative Phosphorylation; D010088:Oxidoreductases; D010101:Oxygen Consumption; D010743:Phospholipids; D051381:Rats; D013386:Succinates / Q000378:metabolism; D013395:Sucrose / Q000494:pharmacology
D005231:Fatty Acids, Unsaturated; D005971:Glutamates; D007656:Ketoglutaric Acids; D010743:Phospholipids; D013386:Succinates; D009249:NADP; D013395:Sucrose; D007501:Iron; D010088:Oxidoreductases; D008274:Magnesium